Skip to main content

Advertisement

Log in

A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging

  • Original Paper
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Children with autism and autism spectrum disorders have a high incidence of neurologic comorbidities. Consequently, evaluation with magnetic resonance imaging (MRI) is deemed necessary. Sedating these patients poses several challenges. This retrospective study compared the efficacy and safety of dexmedetomidine to propofol in sedating autistic patients undergoing MRI. There were 56 patients in the dexmedetomidine group and 49 in the propofol group. All of the patients successfully completed the procedure. Recovery and discharge times were significantly lower in the propofol group, while the dexmedetomidine group maintained more stable hemodynamics. Both propofol and dexmedetomidine proved to be adequate and safe medications in the sedation of autistic children undergoing MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ahmed, S. S., Unland, T., Slaven, J. E., Nitu, M. E., & Rigby, M. R. (2014). Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children. Southern Medical Journal, 107(9), 559–564. https://doi.org/10.14423/SMJ.0000000000000160.

    Article  PubMed  Google Scholar 

  • Berkenbosch, J. W., Wankum, P. C., & Tobias, J. D. (2005). Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatric Critical Care Medicine, 6(4), 435–439. https://doi.org/10.1097/01.PCC.0000163680.50087.93. quiz 440.

    Article  PubMed  Google Scholar 

  • Bhana, N., Goa, K. L., & McClellan, K. J. (2000). Dexmedetomidine. Drugs, 59(2), 263–268; discussion 269–270.

    Article  PubMed  Google Scholar 

  • Canitano, R., Luchetti, A., & Zappella, M. (2005). Epilepsy, electroencephalographic abnormalities, and regression in children with autism. Journal of Child Neurology, 20(1), 27–31. https://doi.org/10.1177/08830738050200010401.

    Article  PubMed  Google Scholar 

  • Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: Confirmation of high prevalence. American Journal of Psychiatry, 162(6), 1133–1141. https://doi.org/10.1176/appi.ajp.162.6.1133.

    Article  PubMed  Google Scholar 

  • Chiaretti, A., Benini, F., Pierri, F., Vecchiato, K., Ronfani, L., Agosto, C., … Barbi, E. (2014). Safety and efficacy of propofol administered by paediatricians during procedural sedation in children. Acta Paediatrica, 103(2), 182–187. https://doi.org/10.1111/apa.12472.

    Article  PubMed  Google Scholar 

  • Coté, C. J., Wilson, S., PEDIATRICS, A. A. O., & DENTISTRY, A. A. O. P. (2016). Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: Update 2016. Pediatrics. https://doi.org/10.1542/peds.2016-1212.

    Google Scholar 

  • Coté, C. J., Wilson, S., Pediatrics, A. A. o., Dentistry, A. A. o., P., & Sedation, W. G. o. (2006). Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: An update. Pediatrics, 118(6), 2587–2602. https://doi.org/10.1542/peds.2006-2780.

    Article  PubMed  Google Scholar 

  • Cravero, J. P., Beach, M. L., Blike, G. T., Gallagher, S. M., Hertzog, J. H., & Consortium, P. S. R. (2009). The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: A report from the Pediatric Sedation Research Consortium. Anesthesia & Analgesia, 108(3), 795–804. https://doi.org/10.1213/ane.0b013e31818fc334.

    Article  Google Scholar 

  • Deegan, R. J. (1992). Propofol: A review of the pharmacology and applications of an intravenous anesthetic agent. American Journal of the Medical Sciences, 304(1), 45–49.

    Article  PubMed  Google Scholar 

  • Diagnostic and Statistical Manual of Mental Disorders. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.

    Google Scholar 

  • Disabilities, C. o. C. W., Pediatrics, S. o. D. B., Committee, B. F. S., & Committee, M. H. I. f. C. W. S. N. P. A. (2006). Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening. Pediatrics, 118(1), 405–420. https://doi.org/10.1542/peds.2006-1231.

    Article  Google Scholar 

  • Dyck, J. B., Maze, M., Haack, C., Vuorilehto, L., & Shafer, S. L. (1993). The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology, 78(5), 813–820.

    Article  PubMed  Google Scholar 

  • Gutstein, H. B., Johnson, K. L., Heard, M. B., & Gregory, G. A. (1992). Oral ketamine preanesthetic medication in children. Anesthesiology, 76(1), 28–33.

    Article  PubMed  Google Scholar 

  • Heard, C., Burrows, F., Johnson, K., Joshi, P., Houck, J., & Lerman, J. (2008). A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging. Anesthesia & Analgesia, 107(6), 1832–1839. https://doi.org/10.1213/ane.0b013e31818874ee.

    Article  Google Scholar 

  • Hertzog, J. H., Dalton, H. J., Anderson, B. D., Shad, A. T., Gootenberg, J. E., & Hauser, G. J. (2000). Prospective evaluation of propofol anesthesia in the pediatric intensive care unit for elective oncology procedures in ambulatory and hospitalized children. Pediatrics, 106(4), 742–747.

    Article  PubMed  Google Scholar 

  • Kallio, A., Scheinin, M., Koulu, M., Ponkilainen, R., Ruskoaho, H., Viinamäki, O., & Scheinin, H. (1989). Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clinical Pharmacology & Therapeutics, 46(1), 33–42.

    Article  Google Scholar 

  • Kamat, P. P., McCracken, C. E., Gillespie, S. E., Fortenberry, J. D., Stockwell, J. A., Cravero, J. P., & Hebbar, K. B. (2015). Pediatric critical care physician-administered procedural sedation using propofol: A report from the Pediatric Sedation Research Consortium Database. Pediatric Critical Care Medicine, 16(1), 11–20. https://doi.org/10.1097/PCC.0000000000000273.

    Article  PubMed  Google Scholar 

  • Kanto, J., & Gepts, E. (1989). Pharmacokinetic implications for the clinical use of propofol. Clinical Pharmacokinetics, 17(5), 308–326. https://doi.org/10.2165/00003088-198917050-00002.

    Article  PubMed  Google Scholar 

  • Koroglu, A., Demirbilek, S., Teksan, H., Sagir, O., But, A. K., & Ersoy, M. O. (2005). Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth, 94(6), 821–824. https://doi.org/10.1093/bja/aei119.

    Article  PubMed  Google Scholar 

  • Koroglu, A., Teksan, H., Sagir, O., Yucel, A., Toprak, H. I., & Ersoy, O. M. (2006). A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesthesia & Analgesia, 103(1), 63–67. https://doi.org/10.1213/01.ANE.0000219592.82598.AA.

    Article  Google Scholar 

  • Kotani, Y., Shimazawa, M., Yoshimura, S., Iwama, T., & Hara, H. (2008). The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neuroscience & Therapeutics, 14(2), 95–106. https://doi.org/10.1111/j.1527-3458.2008.00043.x.

    Article  Google Scholar 

  • Krauss, B., & Green, S. M. (2006). Procedural sedation and analgesia in children. Lancet, 367(9512), 766–780. https://doi.org/10.1016/S0140-6736(06)68230-5.

    Article  PubMed  Google Scholar 

  • Lubisch, N., Roskos, R., & Berkenbosch, J. W. (2009). Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatric Neurology, 41(2), 88–94. https://doi.org/10.1016/j.pediatrneurol.2009.02.006.

    Article  PubMed  Google Scholar 

  • Mason, K. P., Sanborn, P., Zurakowski, D., Karian, V. E., Connor, L., Fontaine, P. J., & Burrows, P. E. (2004). Superiority of pentobarbital versus chloral hydrate for sedation in infants during imaging. Radiology, 230(2), 537–542. https://doi.org/10.1148/radiol.2302030107.

    Article  PubMed  Google Scholar 

  • Mason, K. P., Zgleszewski, S. E., Dearden, J. L., Dumont, R. S., Pirich, M. A., Stark, C. D., … Zurakowski, D. (2006). Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesthesia & Analgesia, 103(1), 57–62. https://doi.org/10.1213/01.ane.0000216293.16613.15.

    Article  Google Scholar 

  • Mehta, U. C., Patel, I., & Castello, F. V. (2004). EEG sedation for children with autism. Journal of Developmental & Behavioral Pediatrics, 25(2), 102–104.

    Article  Google Scholar 

  • Myers, S. M., Johnson, C. P., & Disabilities, A. A. o. P. C. o. C. W. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182. https://doi.org/10.1542/peds.2007-2362.

    Article  PubMed  Google Scholar 

  • Rainey, L., & van der Walt, J. H. (1998). The anaesthetic management of autistic children. Anaesth Intensive Care, 26(6), 682–686.

    PubMed  Google Scholar 

  • Seid, M., Sherman, M., & Seid, A. B. (1997). Perioperative psychosocial interventions for autistic children undergoing ENT surgery. International Journal of Pediatric Otorhinolaryngology, 40(2–3), 107–113.

    Article  PubMed  Google Scholar 

  • Shelly, M. P. (2001). Dexmedetomidine: a real innovation or more of the same? British Journal of Anaesthesia, 87(5), 677–678.

    Article  PubMed  Google Scholar 

  • Sulton, C., McCracken, C., Simon, H. K., Hebbar, K., Reynolds, J., Cravero, J., … Kamat, P. (2016). Pediatric procedural sedation using dexmedetomidine: A Report From the Pediatric Sedation Research Consortium. Hospital Pediatrics, 6(9), 536–544. https://doi.org/10.1542/hpeds.2015-0280.

    Article  PubMed  Google Scholar 

  • Tramèr, M. R., Moore, R. A., & McQuay, H. J. (1997). Propofol and bradycardia: causation, frequency and severity. British Journal of Anaesthesia, 78(6), 642–651.

    Article  PubMed  Google Scholar 

  • Vardi, A., Salem, Y., Padeh, S., Paret, G., & Barzilay, Z. (2002). Is propofol safe for procedural sedation in children? A prospective evaluation of propofol versus ketamine in pediatric critical care. Critical Care Medicine, 30(6), 1231–1236.

    Article  PubMed  Google Scholar 

  • Weerink, M. A. S., Struys, M. M. R. F., Hannivoort, L. N., Barends, C. R. M., Absalom, A. R., & Colin, P. (2017). Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clinical Pharmacokinectics, 56(8), 893–913. https://doi.org/10.1007/s40262-017-0507-7.

    Article  Google Scholar 

Download references

Acknowledgments

The authors have reported that no funding was received for this study.

Author information

Authors and Affiliations

Authors

Contributions

KA helped gathering data, conceptualizing and drafting the initial manuscript, and approved the final manuscript as submitted. RL and RL carried out the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted. SSA designed and conceptualized the study, and coordinated and supervised data collection, critically reviewed and approved the final manuscript as submitted.

Corresponding author

Correspondence to Kamal Abulebda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abulebda, K., Louer, R., Lutfi, R. et al. A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging. J Autism Dev Disord 48, 3127–3132 (2018). https://doi.org/10.1007/s10803-018-3582-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-018-3582-1

Keywords

Navigation